ATAI Life Sciences NV (ATAI)
1.95
-0.20
(-9.30%)
USD |
NASDAQ |
Apr 17, 16:00
1.98
+0.03
(+1.54%)
After-Hours: 20:00
ATAI Life Sciences Net Income (TTM): -40.22M for Dec. 31, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -40.22M |
| September 30, 2023 | -66.94M |
| June 30, 2023 | -145.08M |
| March 31, 2023 | -148.65M |
| December 31, 2022 | -152.38M |
| September 30, 2022 | -196.25M |
| June 30, 2022 | -193.52M |
| Date | Value |
|---|---|
| March 31, 2022 | -205.36M |
| December 31, 2021 | -167.81M |
| September 30, 2021 | -165.52M |
| June 30, 2021 | -217.56M |
| March 31, 2021 | -185.46M |
| December 31, 2020 | -169.84M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-217.56M
Minimum
Jun 2021
-40.22M
Maximum
Dec 2023
-158.05M
Average
-167.81M
Median
Dec 2021
Net Income (TTM) Benchmarks
| Affimed NV | -114.68M |
| InflaRx NV | -46.12M |
| MorphoSys AG | -206.62M |
| BioNTech SE | 999.74M |
| Immatics NV | -105.04M |